United States onlyRhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
As a Field Access Manager (FAM), you will partner with internal and external stakeholders to facilitate removal of access related barriers, providing pull through and issue resolution supporting physicians prescribing IMCIVREE. This role requires a deep understanding of payer dynamics, and you will serve as subject matter expert for access related challenges, supporting patient services, market access, territory managers, specialty pharmacy partners, and prescribing physicians. You will identify payer trends, educate matrix partners, while executing tactical plans to expedite payer approval. This role is field based, will be responsible for the Southeast territory, and will report into the Director, Patient and Customer Operations.
Responsibilities and Duties
- Identify and resolve access related barriers to support physicians in the payer approval process of IMCIVREE
- Implement case specific plans based on payer mix, benefit design and authorization requirements
- Manage the pharmacy benefit approval process from prior authorization through any necessary appeals, providing oversight to specialty pharmacy partners to ensure pull through of insurance approvals
- Establish trusted relationships with key accounts, delivering education to optimize patient specific access
- Lead local level access related strategies, develop regional best practices that streamline the prior authorization/appeal process and expedite treatment access
- Inform strategy through communication of marketplace changes and payer intelligence gained from key customers
- Meet documentation requirements of CRM system to facilitate tracking of critical metrics
- Deliver on key objectives established annually and demonstrate accountability for execution and drive for results
- Ensures full compliance with all corporate and industry policies and legal and regulatory requirements
- Bachelor’s degree required
- 6+ years’ experience working within Rare Disease in commercial, with a background in Case Management (access/reimbursement)
- Demonstrated successful navigation of complex authorization processes for Specialty Medications
- Results driven
- Prior product launch experience preferred
- Ability to work independently and collaboratively within a diverse team
- Excellent communication and relationship building skills
- Demonstrated analytical, problem solving
- Ability to travel within the US (up to 30%)
More about Rhythm
Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them. We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.
Belgium only
